252 related articles for article (PubMed ID: 22028447)
1. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
Li Q; Hosaka T; Shikama Y; Bando Y; Kosugi C; Kataoka N; Nakaya Y; Funaki M
Endocrinology; 2012 Jan; 153(1):56-68. PubMed ID: 22028447
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes.
Usui I; Imamura T; Babendure JL; Satoh H; Lu JC; Hupfeld CJ; Olefsky JM
Mol Endocrinol; 2005 Nov; 19(11):2760-8. PubMed ID: 15994203
[TBL] [Abstract][Full Text] [Related]
3. Role of growth factor receptor transactivation in high glucose-induced increased levels of Gq/11alpha and signaling in vascular smooth muscle cells.
Descorbeth M; Anand-Srivastava MB
J Mol Cell Cardiol; 2010 Aug; 49(2):221-33. PubMed ID: 20036247
[TBL] [Abstract][Full Text] [Related]
4. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
[TBL] [Abstract][Full Text] [Related]
5. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes.
Hardy RW; Gupta KB; McDonald JM; Williford J; Wells A
Endocrinology; 1995 Feb; 136(2):431-9. PubMed ID: 7835273
[TBL] [Abstract][Full Text] [Related]
7. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
Adochio R; Leitner JW; Hedlund R; Draznin B
Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
[TBL] [Abstract][Full Text] [Related]
8. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
[TBL] [Abstract][Full Text] [Related]
9. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
10. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons.
Farkas LM; Krieglstein K
J Neural Transm (Vienna); 2002 Mar; 109(3):267-77. PubMed ID: 11956950
[TBL] [Abstract][Full Text] [Related]
12. Role of metalloproteinase-dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons.
Shah BH; Shah FB; Catt KJ
J Neurochem; 2006 Jan; 96(2):520-32. PubMed ID: 16336626
[TBL] [Abstract][Full Text] [Related]
13. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.
Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C
Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045
[TBL] [Abstract][Full Text] [Related]
14. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1-stimulated glucose uptake is desensitized by tumor necrosis factor-alpha in 3T3-L1 adipocytes.
Rachdaoui N; Nagy LE
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E545-51. PubMed ID: 12773307
[TBL] [Abstract][Full Text] [Related]
16. Gq protein mediates UVB-induced cyclooxygenase-2 expression by stimulating HB-EGF secretion from HaCaT human keratinocytes.
Seo M; Juhnn YS
Biochem Biophys Res Commun; 2010 Mar; 393(2):190-5. PubMed ID: 20117092
[TBL] [Abstract][Full Text] [Related]
17. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
Jin K; Mao XO; Del Rio Guerra G; Jin L; Greenberg DA
J Neurosci Res; 2005 Aug; 81(4):497-505. PubMed ID: 15952178
[TBL] [Abstract][Full Text] [Related]
19. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
Göőz M; Göőz P; Luttrell LM; Raymond JR
J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
[TBL] [Abstract][Full Text] [Related]
20. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
